2024-10-31 - Analysis Report
## AbbVie Inc. (ABBV) Stock Analysis Report

**Company Overview:** AbbVie Inc. is a global pharmaceutical company that researches, develops, manufactures and markets a broad portfolio of medicines across various therapeutic areas including immunology, oncology, neuroscience, and eye care.

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** ABBV (146.24%) vs. VOO (136.74%)
* **Outperformance:** ABBV outperforms VOO by **9.5%**.
* **Relative Outperformance:** This outperformance represents **51.61%** of the historical maximum outperformance range.

**2. Recent Price Movements:**

* **Closing Price:** $189.45 (Last market: $196.31)
* **5-day Moving Average:** $188.90
* **20-day Moving Average:** $191.58
* **60-day Moving Average:** $193.32
* **Observations:** The stock is currently trading below its 5, 20, and 60-day moving averages, indicating a potential short-term downward trend. The last market price of $196.31 suggests a recent spike, which could be a sign of potential volatility. 

**3. Technical Indicators:**

* **RSI:** 37.04 - This suggests that the stock is currently in oversold territory, potentially indicating a rebound in the near future.
* **PPO:** -0.13 - A negative PPO value implies a downward trend in price momentum, aligning with the current price movement below the moving averages.
* **Delta_Previous_Relative_Divergence:** -13.77 (-) - Indicates a short-term downward trend in relative price strength.
* **Expected Return:** 3.02% - This suggests that ABBV could potentially generate a higher return than the S&P 500 over the long term (2+ years).

**4. Recent Earnings Performance:**

| Date | EPS | Expected EPS | 
|---|---|---|
| 2024-07-25 | 2.65 | 2.57 | 
| 2024-04-26 | 2.31 | 2.26 | 
| 2024-02-02 | 2.79 | 2.76 | 
| 2023-10-27 | 2.95 | 2.86 | 
| 2023-07-27 | 2.91 | 2.79 |

* **Most Recent Earnings:** ABBV exceeded expectations in the most recent quarter (2024-07-25), reporting EPS of $2.65 against an estimated $2.57. 
* **Earnings Trend:** Overall, ABBV has consistently exceeded earnings expectations, demonstrating strong profitability. However, it's worth noting that the earnings growth rate is slowing down.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-06-30 | $14.46B | 70.94% |
| 2024-03-31 | $12.31B | 66.74% |
| 2023-12-31 | $14.30B | 60.11% |
| 2023-09-30 | $13.93B | 53.44% |
| 2023-06-30 | $13.87B | 69.42% |

* **Revenue:** ABBV consistently generates strong revenue with a slight dip in Q1 2024.
* **Profit Margin:** The company enjoys a high profit margin, indicating strong efficiency and cost management.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $6.78B | 20.21% |
| 2024-03-31 | $8.01B | 17.10% |
| 2023-12-31 | $10.36B | 7.93% |
| 2023-09-30 | $12.09B | 14.70% |
| 2023-06-30 | $12.87B | 15.73% |

* **Equity:**  Fluctuating equity values demonstrate potential investments and acquisitions.
* **ROE:** ABBV exhibits a strong return on equity, highlighting its ability to generate profits from its assets.

**6. News and Recent Issues:**

* **Earnings Releases:** Recent earnings releases from Shacknews (and other reliable sources) are crucial to track, as they provide real-time insights into company performance.
* **Market Outlook:** Research recent market outlooks for ABBV from reputable financial websites like Finbold.
* **Analyst Opinions:** Seek out analyst ratings and target prices for ABBV. These provide valuable insights into the overall sentiment surrounding the stock.
* **Performance Highlights:** Analyze any recent company announcements or news that may affect stock performance.

**7. Comprehensive Analysis:**

ABBV exhibits strong financial fundamentals, consistently delivering solid earnings and revenue growth. The company enjoys a high profit margin and robust return on equity, reflecting its efficient operations and strong profitability. However, recent price movements suggest a potential short-term downward trend. Technical indicators point towards an oversold situation, potentially indicating a rebound.

**Key Considerations:**

* **Competition:** The pharmaceutical industry is highly competitive. ABBV needs to maintain innovation and develop new drugs to stay ahead.
* **Regulatory Environment:** Pharmaceutical companies face significant regulatory hurdles, which could impact profitability.
* **Pricing Pressure:**  The company may face pressure from payers to reduce drug prices.

**Overall:**

ABBV presents an attractive investment opportunity for long-term investors seeking a dividend-paying company with strong fundamentals and growth potential.  The stock's recent performance suggests short-term volatility, but its overall financial strength and long-term growth prospects make it a worthy consideration.

**Note:** This analysis is based on the provided data and should be considered as a starting point for further research and evaluation. It's always recommended to consult with a financial advisor before making any investment decisions.